Skip to main content

Articles

Leukemia, Oncology

New Oral TKI Ponatinib Produces High Response Rates in Hard-to-Treat Leukemia

Rivaroxaban More Cost-Effective than Warfarin for Recurrent VTE Prevention

Costs of Second-Line Metastatic Colorectal Cancer Treatments Compared

Combined Chemoradiation Cost-Effective in Younger Patients with Primary CNS Lymphoma

Rasburicase Cost-Effective for Tumor Lysis Syndrome

Internet-Based Tool Helps Guide Treatment Decisions in Patients with CML

Faster Rituximab Infusion Lowers Cost

Selective JAK Inhibitor Cost-Effective Option for Patients with Myelofibrosis

Leukemia, Oncology

New Targeted Agent Shows Significant Success in Treating Refractory Form of AML

Hematologic Drug Pipeline Is Bustling

Page 184 of 244
Results 1831 - 1840 of 2434